rs768737101
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PP3_ModeratePP5_Very_Strong
The NM_003737.4(DCHS1):c.6988C>T(p.Arg2330Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_003737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249888Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135114
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461392Hom.: 0 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 726968
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
not provided Pathogenic:5
- -
The DCHS1 p.R2330C variant was identified in the literature to segregate with disease in seven individuals with mitral valve prolapse from two families. Individuals with this variant in both families had mild to severe mitral valve prolapse phenotypes; an eighth family member also carried the p.R2330C variant but his mitral valve prolapse status was unknown (Durst_2015_PMID:26258302). The variant was identified in dbSNP (ID: rs768737101) and ClinVar (reported as pathogenic by OMIM). The variant was identified in control databases in 7 of 281266 chromosomes at a frequency of 0.00002489 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 6 of 127984 chromosomes (freq: 0.000047) and South Asian in 1 of 30584 chromosomes (freq: 0.000033), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), or Other populations. The p.R2330 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. Functional data in mitral valve interstitial cells demonstrated a significant reduction in protein half-life with this variant compared to wildtype. Furthermore, an in vitro mice study of mitral valve interstitial cells from a mitral valve prolapse proband showed an abnormal cell migration pattern, providing support for this variant's pathogenicity (Durst_2015_PMID:26258302). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more pathogenic role for this variant. This variant is classified as likely pathogenic. -
- -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 2330 of the DCHS1 protein (p.Arg2330Cys). This variant is present in population databases (rs768737101, gnomAD 0.005%). This missense change has been observed in individual(s) with autosomal dominant mitral valve prolapse (PMID: 26258302). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 217871). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DCHS1 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
- -
Mitral valve prolapse, myxomatous 2 Pathogenic:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at